According to the research report titled ‘Global Transcatheter Pulmonary Valve Replacement (TPVR) Market a?? Analysis By Application Type, By End User, By Region, By Country (2020 Edition): Market Insights, Competition and Forecast (2020-2025)’, available with Market Study Report, global transcatheter pulmonary valve replacement (TPVR) industry size was valued USD 287.6 million in 2019 and is anticipated to expand at healthy growth rate through 2025.
 

Increasing prevalence of cardiovascular diseases and growing inclination towards minimally invasive procedures are fueling global transcatheter pulmonary valve replacement (TPVR) market growth. Besides, innovation in TPVR technology is enhancing the industry outlook. Further, large scale investments by market majors in expanding their product portfolio and geographical presence is slated to positively sway the market dynamics in the upcoming years, claims the study.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2752224/
 

For the record, the market is currently characterized by the presence of only three FDA approved products. With several products still at the clinical stage, growth opportunities are expected to spring up in the forthcoming years.
 

Based on application type, global transcatheter pulmonary valve replacement (TPVR) market is divided into pulmonary regurgitation, pulmonary stenosis, and others. Of these, pulmonary regurgitation is expected capture majority industry share in the coming years, attributable to growing adoption of less invasive procedures, shifting preference from SAVR to TVR, and low cost offerings by major players.
 

Elaborating on end-user spectrum, hospitals and ambulatory surgical centers currently capture a sizeable portion of global transcatheter pulmonary valve replacement (TPVR) market share, largely creditable to growing R&D investment backed up by reviving economic growth and escalating cases of valvular diseases.
 

From a geographical perspective, Europe is touted to lead global transcatheter pulmonary valve replacement (TPVRR) market growth, followed by North America and Asia Pacific. Surging demand for minimally invasive procedures, positive economic outlook, rising cases of pulmonary regurgitation & pulmonary stenosis, along with growing presence of key players are supporting the industry growth in Europe.
 

Speaking of the competitive arena, global transcatheter pulmonary valve replacement (TPVR) industry is oligopolistic in nature. Edwards Lifesciences Corporation, Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, and Venus MedTech (HangZhou) Incorporated are the prominent players in this domain.